Young men and minority patients with early-onset CRC in urban areas face higher CVD death risk, challenging assumptions about ...

Urinary tract endometriosis may mimic recurrent UTI, and PID-like symptom clusters can divert workup toward infection, necessitating reassessment when symptoms persist without clear infectious source.

Training deficits in STS brachytherapy stem primarily from limited resident case exposure, despite broad perceived importance ...

Nirogacestat (Ogsiveo; Springworks Therapeutics) is a therapy used to treat desmoid tumors, rare but aggressive growths that ...

Reproductive-care access remains unsettled as mifepristone telehealth/mail distribution is temporarily protected by the ...

High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance design should eliminate patient cost sharing for these therapies. Cell and ...

Swarup Kumar, MD, discusses how bispecific antibodies are pushing myeloma cure rates to 40%—and what clinicians must know ...

The heart failure (HF) treatment landscape continues to evolve rapidly in 2026, with emerging evidence pointing toward a ...

Federal complaints by University of Michigan, University of Kansas Hospital Authority, and Mount Sinai entities seek recovery of approximately $250 million in alleged 340B savings diversion from ...

USPSTF recommendations have statutory coverage implications under the ACA, mandating no-cost coverage for graded preventive services and directly shaping access to mammography, colorectal screening, ...

Average Marketplace deductibles rose from $2,759 (2025) to $3,786 (2026), predominantly reflecting plan-mix changes; holding 2025 selection constant would have yielded a 6% increase. Bronze enrollment ...

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...